Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Børre Fevang. (2023) Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives. Expert Review of Clinical Immunology 19:6, pages 627-638.
Read now
Read now
Articles from other publishers (16)
Abbas Jafari-Kashi, Mehdi Shabani-Nooshabadi & Hossain-Ali Rafiee-Pour. (2023) Determination of bortezomib and dasatinib anticancer drugs in real samples using an electrochemical sensor modified with new CuFe2O4/SmVO4/ionic liquid nanocomposite. Carbon Letters.
Crossref
Crossref
Faryal Munir, Viney Hardit, Irtiza N. Sheikh, Shaikha AlQahtani, Jiasen He, Branko Cuglievan, Chitra Hosing, Priti Tewari & Sajad Khazal. (2023) Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances. International Journal of Molecular Sciences 24:12, pages 10095.
Crossref
Crossref
Caroline Markmann & Vijay G. Bhoj. (2021) On the road to eliminating long‐lived plasma cells—“are we there yet?”. Immunological Reviews 303:1, pages 154-167.
Crossref
Crossref
Qingnian Goh, Sia Nikolaou, Kritton Shay‐Winkler, Marianne E. Emmert & Roger Cornwall. (2020) Timing of proteasome inhibition as a pharmacologic strategy for prevention of muscle contractures in neonatal brachial plexus injury. The FASEB Journal 35:2.
Crossref
Crossref
Tristan Knight, Yaddanapudi Ravindranath & Michael U. Callaghan. (2020) Successful Treatment of an Adolescent Male With Severe Refractory Evans Syndrome Using Bortezomib-based Therapy. Journal of Pediatric Hematology/Oncology 42:2, pages e110-e113.
Crossref
Crossref
Sia Nikolaou, Alyssa A.W. Cramer, Liangjun Hu, Qingnian Goh, Douglas P. Millay & Roger Cornwall. (2019) Proteasome inhibition preserves longitudinal growth of denervated muscle and prevents neonatal neuromuscular contractures. JCI Insight 4:23.
Crossref
Crossref
Jaitri Joshi, Lynn Tanner, Laura Gilchrist & Bruce Bostrom. (2019) Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 41:6, pages 457-462.
Crossref
Crossref
Stefania Crisci, Filomena Amitrano, Mariangela Saggese, Tommaso Muto, Sabrina Sarno, Sara Mele, Pasquale Vitale, Giuseppina Ronga, Massimiliano Berretta & Raffaele Di Francia. (2019) Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology. Medicina 55:8, pages 414.
Crossref
Crossref
Sathish Kumar, Rina Barouch-Bentov, Fei Xiao, Stanford Schor, Szuyuan Pu, Elise Biquand, Albert Lu, Brett D. Lindenbach, Yves Jacob, Caroline Demeret & Shirit Einav. (2019) MARCH8 Ubiquitinates the Hepatitis C Virus Nonstructural 2 Protein and Mediates Viral Envelopment. Cell Reports 26:7, pages 1800-1814.e5.
Crossref
Crossref
Benjamin Bonavida. 2019. Cancer Stem Cell Resistance to Targeted Therapy. Cancer Stem Cell Resistance to Targeted Therapy
93
113
.
Ioannis Panagopoulos, Ludmila Gorunova, Hege Kilen Andersen, Astrid Bergrem, Anders Dahm, Kristin Andersen, Francesca Micci & Sverre Heim. (2018) PAN3–PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia. Experimental Hematology & Oncology 7:1.
Crossref
Crossref
Makeda Robinson, Stanford Schor, Rina Barouch-Bentov & Shirit Einav. (2018) Viral journeys on the intracellular highways. Cellular and Molecular Life Sciences 75:20, pages 3693-3714.
Crossref
Crossref
F Buontempo, J A McCubrey, E Orsini, M Ruzzene, A Cappellini, A Lonetti, C Evangelisti, F Chiarini, C Evangelisti, J T Barata & A M Martelli. (2017) Therapeutic targeting of CK2 in acute and chronic leukemias. Leukemia 32:1, pages 1-10.
Crossref
Crossref
Ranjan Bista, David W. Lee, Oliver B. Pepper, David O. Azorsa, Robert J. Arceci & Eiman Aleem. (2017) Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells. Journal of Experimental & Clinical Cancer Research 36:1.
Crossref
Crossref
Mariette Matondo, Marlène Marcellin, Karima Chaoui, Marie-Pierre Bousquet-Dubouch, Anne Gonzalez-de-Peredo, Bernard Monsarrat & Odile Burlet-Schiltz. (2017) Determination of differentially regulated proteins upon proteasome inhibition in AML cell lines by the combination of large-scale and targeted quantitative proteomics. PROTEOMICS 17:7, pages 1600089.
Crossref
Crossref
Magdalena Mazurkiewicz, Ellin-Kristina Hillert, Xin Wang, Paola Pellegrini, Maria Hägg Olofsson, Karthik Selvaraju, Padraig D’Arcy & Stig Linder. (2017) Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition. Oncotarget 8:13, pages 21115-21127.
Crossref
Crossref